about
Hematopoietic and mesenchymal stem cells for the treatment of chronic respiratory diseases: role of plasticity and heterogeneityRole of Sphingolipids in the Pathobiology of Lung InflammationPseudomonas aeruginosa N-3-oxo-dodecanoyl-homoserine Lactone Elicits Changes in Cell Volume, Morphology, and AQP9 Characteristics in MacrophagesPulmonary emphysema in cystic fibrosis detected by densitometry on chest multidetector computed tomographyReduced GM1 ganglioside in CFTR-deficient human airway cells results in decreased β1-integrin signaling and delayed wound repairβ1-Integrin Accumulates in Cystic Fibrosis Luminal Airway Epithelial Membranes and Decreases Sphingosine, Promoting Bacterial InfectionsModifications of Pseudomonas aeruginosa cell envelope in the cystic fibrosis airway alters interactions with immune cells.Macropinocytosis of extracellular glutathione ameliorates tumor necrosis factor α release in activated macrophages.Quantitative imaging of airway liquid absorption in cystic fibrosis.BIIL 284 reduces neutrophil numbers but increases P. aeruginosa bacteremia and inflammation in mouse lungs.Sphingoid long chain bases prevent lung infection by Pseudomonas aeruginosa.Expression of PPARγ and paraoxonase 2 correlated with Pseudomonas aeruginosa infection in cystic fibrosis.Airway mucus obstruction triggers macrophage activation and matrix metalloproteinase 12-dependent emphysema.Clinical significance of microbial infection and adaptation in cystic fibrosis.Myofibroblast differentiation and enhanced TGF-B signaling in cystic fibrosis lung disease.Mature cystic fibrosis airway neutrophils suppress T cell function: evidence for a role of arginase 1 but not programmed death-ligand 1.CFTR is required for maximal transepithelial liquid transport in pig alveolar epithelia.Myriocin treatment of CF lung infection and inflammation: complex analyses for enigmatic lipids.Prospective multicenter study of Pneumocystis jirovecii colonization among cystic fibrosis patients in France.Neutrophil in viral infections, friend or foe?Impaired defenses of neonatal mouse alveolar macrophage with cftr deletion are modulated by glutathione and TGFβ1Improved outcomes of patients with end-stage cystic fibrosis requiring invasive mechanical ventilation for acute respiratory failure.Lipids in cystic fibrosis.Immune responses in cystic fibrosis: are they intrinsically defective?From micellar electrokinetic chromatography to liquid chromatography-mass spectrometry: revisiting the way of analyzing human fluids for the search of desmosines, putative biomarkers of chronic obstructive pulmonary disease.The Role of Human Beta-Defensin-2 in Pseudomonas aeruginosa Pulmonary Infection in Cystic Fibrosis Patients.Current and future therapies for Pseudomonas aeruginosa infection in patients with cystic fibrosis.Sphingolipids in neutrophil function and inflammatory responses: Mechanisms and implications for intestinal immunity and inflammation in ulcerative colitis.Lactoferrin decreases inflammatory response by cystic fibrosis bronchial cells invaded with Burkholderia cenocepacia iron-modulated biofilm.Th17/Treg imbalance in murine cystic fibrosis is linked to indoleamine 2,3-dioxygenase deficiency but corrected by kynurenines.Reduced surface toll-like receptor-4 expression and absent interferon-γ-inducible protein-10 induction in cystic fibrosis airway cells.Ceramide mediates lung fibrosis in cystic fibrosis.Ceramide in cystic fibrosis: a potential new target for therapeutic intervention.Nano-based theranostics for chronic obstructive lung diseases: challenges and therapeutic potential.Modulating the alveolar milieu to enhance resolution of fibrotic lung injury.Lactate levels in airways of patients with cystic fibrosis and idiopathic pulmonary fibrosis.N-Acylhomoserine lactones are potent neutrophil chemoattractants that act via calcium mobilization and actin remodeling.
P2860
Q21284513-C0A029B2-DE6C-4F91-ACC5-32EBA8C8D0E6Q26771956-9117B04A-4AD3-4960-97BE-997093ABB6E0Q27330172-162A9927-0C00-45A5-9069-E3B1EEC3D461Q31133549-45FE7FDC-20CD-4F4C-8214-12E849EFA597Q33569399-7A1CF57E-C0FD-4C8F-88A8-6F6CF35EC305Q33811046-6CB26DC7-3914-407E-B5EF-91EF695FC949Q33881822-D5992CB3-98A4-4CA6-B541-693FB778F314Q34047082-C5F1F138-A456-4BC7-BBBB-92EFDC995598Q34115805-489A7E16-872C-4AAF-9234-4FC3988D3122Q34180324-FEDFBBB4-19A6-4C84-8B4F-139D4E683435Q34342508-8BD13A0B-EEA9-44B0-9CD0-297A35BECE2DQ34364700-33A4D976-4DA9-4F9B-B832-C9C6CDD1258BQ34419996-DEEAFE28-2D3C-45C3-903D-F0AEF9E37C13Q34491552-4C4881B3-A5FC-4B07-ACD1-B8D980FE0F67Q34946558-5998F812-5398-49D2-B382-C063A9BE36ABQ35613230-520C635D-5A2D-40C3-BA31-DD6704210B03Q36115249-FF64CB91-278C-49E0-95A0-3AFDDFD91694Q36355889-8F4A230E-502A-43A2-9646-38F5A85A11D0Q36414080-866BE2D7-681F-4FC9-A0C8-96D1E502F55BQ36569374-5A148008-9191-4980-B914-CB0C231B4BF2Q37727368-67416D02-56F7-4977-9E16-25BACD50BD0EQ37909115-018CF331-BBDC-4500-AC8E-EB4B7C792D55Q37920895-E0F36149-B58A-41D4-9184-2CD0ECB3DD70Q37992061-D158458A-B051-4867-BDCA-569D7BC65028Q38176305-1142F7E3-2AAB-438E-A9AA-D9012E468FBCQ38240975-8AA9F209-8137-4B0B-BEB3-E4066B5F6B57Q38635530-005AA7E3-83C7-4123-B1C2-40FF99FD4B95Q39014759-83FD88A2-28B8-4D79-9DF0-A05B54A16845Q39414991-230991FE-E94B-4C2C-B07A-C71E0766B9F4Q39488014-BEC335B3-9FBC-47E1-B54D-0EF0CCBACAE1Q39529201-29BC056C-9C60-45B0-BC34-283FC6905622Q39884057-FCF306AE-FB49-474C-A9D8-739B26B79252Q42005356-3B123B8C-0C79-4FD5-A0AA-B65D657C7705Q42873072-10AD1432-FD82-4F10-B3AD-622A12C422B6Q44705673-A88065CF-095D-44FD-AA1F-0DC1E6D7BBC5Q50866433-CDB32774-7647-4914-B54C-FF26ED573C71Q53228642-60DE1394-2CE4-409C-9CC2-AEC46655B25E
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Alveolar inflammation in cystic fibrosis.
@ast
Alveolar inflammation in cystic fibrosis.
@en
type
label
Alveolar inflammation in cystic fibrosis.
@ast
Alveolar inflammation in cystic fibrosis.
@en
prefLabel
Alveolar inflammation in cystic fibrosis.
@ast
Alveolar inflammation in cystic fibrosis.
@en
P2093
P2860
P1476
Alveolar inflammation in cystic fibrosis.
@en
P2093
Antje Schuster
Dieter Worlitzsch
Felix Ratjen
Gerald B Pier
Gerd Döring
Godehard Friedel
Janis K Shute
Keith C Meyer
Marianne Geiser
Mark L Barr
P2860
P304
P356
10.1016/J.JCF.2010.03.001
P577
2010-03-29T00:00:00Z